Pulmonary Embolism (ED Pathway)
- Pulmonary embolism (PE) is a clot lodged in the lung's arteries — but the ED question isn't "is there a clot?", it's "who actually needs the scan?"
- Risk-stratify before you image. A validated clinical score (like Wells) plus a D-dimer keeps low-risk patients out of the CT scanner.
- The workhorse test is CT pulmonary angiography (CTPA): a timed contrast bolus that lights up the pulmonary arteries so a clot shows up as a dark filling defect.
- Timing is everything — if the contrast peaks too early or too late, the arteries look gray and the study is uninterpretable.
- Don't stop at the clot. Look for the right heart strain that tells you how scared to be.
Someone rolls into the ED short of breath with a racing heart, and the resident's first instinct is to scan everyone — chest, top to bottom, contrast and all. Resist that. The pulmonary embolism pathway is less about heroic image interpretation and more about asking the right questions in the right order, so that the scanner gets the patients who need it and the rest go home without a needless dose of radiation and iodine. Let me walk you through the order.
Step one: decide before you scan
A pulmonary embolism is a blood clot — usually one that broke off a leg vein and traveled north — that wedges into a pulmonary artery and blocks flow. The trouble is that PE is a champion mimic: chest pain, breathlessness, a fast pulse. Half of cardiology and most of anxiety look the same.
So the pathway starts with a clinical decision rule, most commonly the Wells score, which tallies up risk factors (recent surgery, a swollen leg, prior clots, and so on) into a probability bucket. Think of it as a bouncer at the door of the CT scanner — it decides who's even allowed to ask for a ticket.
For patients who score low, a normal D-dimer blood test essentially closes the case — no scan needed. D-dimer is a fragment shed when the body breaks down clot. A negative result in a low-risk patient is reassuring; a positive result is frustratingly nonspecific, because infection, pregnancy, cancer, and simply being old will all raise it. It rules out, it doesn't rule in.
That's the whole trick of the front end: the D-dimer is a great "go home" test and a terrible "you definitely have a clot" test. Use it to keep low-risk people out of the scanner, not to confirm disease.
Step two: CT pulmonary angiography, the workhorse
Once someone clears the bouncer — high-risk, or low-risk with a positive D-dimer — the test is CT pulmonary angiography (CTPA): a chest CT timed so the IV contrast is sitting in the pulmonary arteries at the exact moment the scanner fires.
Picture pouring cream into a cup of black coffee and trying to photograph the swirl. Too early, the cream hasn't arrived; too late, it's all mixed and muddy. CTPA chases that perfect instant when the pulmonary arteries are bright white with contrast. Against that bright background, a clot shows up as a filling defect — a dark plug sitting inside a glowing vessel, like a cork bobbing in a lit-up pipe.
The mechanics of getting that contrast bolus to peak in the right vessel at the right second are the same physics behind every CTA and MRA — worth a detour if the timing piece feels hand-wavy.
Step three: judge the timing before you judge the clot
Here's the rookie trap. Before you call a study negative, make sure it was actually diagnostic. If the contrast bolus mistimed, the pulmonary arteries come out gray instead of brilliant white, and a real clot can hide in that murk.
A "negative" CTPA on a poorly timed bolus is not negative — it's non-diagnostic. If the pulmonary arteries aren't densely opacified, you cannot confidently exclude PE. Look at the vessel density first; only then go hunting for filling defects.
A related gremlin: breathing and motion. A patient gasping for air rarely holds a perfect breath, and respiratory motion smears the vessels into blurry streaks that masquerade as clot. Knowing it's an artifact — not a thrombus — is half the battle.
Step four: don't stop at the clot — read the heart
Finding the embolus is the obvious win. The grown-up move is asking how much trouble it's causing. A clot that throttles enough of the lung's circulation backs pressure up into the right ventricle, which is a thin-walled chamber built for low pressure — it strains and dilates fast.
On the same CTPA, glance at the heart. A right ventricle that looks bigger than the left, or an interventricular septum bowing toward the left side like an overinflated balloon pushing on its neighbor, signals right heart strain. That's the difference between a clot you note and a clot that changes the patient's disposition.
This is also where the source of the problem connects back: most of these clots are migrants from a deep vein thrombosis in the legs, which is why the leg veins and the lung arteries are really two ends of the same disease.
A quick map of the pathway
| Stage | Question | Tool |
|---|---|---|
| Risk stratify | How likely is PE? | Clinical score (e.g. Wells) |
| Low risk | Can I avoid imaging? | D-dimer (rules out) |
| Imaging | Where's the clot? | CTPA filling defect |
| Quality check | Is the study even readable? | Pulmonary artery contrast density |
| Severity | How bad is it? | Right heart strain |
One last thing: contrast isn't free
CTPA needs a hefty slug of iodinated contrast, so the pathway has to bend for the patient in front of you — impaired kidneys, a prior reaction, or pregnancy can all push you toward alternatives like a ventilation–perfusion scan. If contrast is on the table, it's worth knowing how to spot and handle a contrast reaction before you push the injector.
If you remember one thing: the PE pathway is a series of gates, not a single scan. The clinical score and D-dimer decide whether to image, the contrast timing decides whether the image is trustworthy, and the right ventricle tells you how worried to be. Get those gates in order and the clot itself is the easy part.